Cargando…
Luminal breast cancer metastases and tumor arousal from dormancy are promoted by direct actions of estradiol and progesterone on the malignant cells
INTRODUCTION: Luminal, estrogen receptor-positive (ER(+)) breast cancers can metastasize but lie dormant for years before recurrences prove lethal. Understanding the roles of estrogen (E) or progestin (P) in development of luminal metastases or in arousal from dormancy is hindered by few preclinical...
Autores principales: | Ogba, Ndiya, Manning, Nicole G, Bliesner, Brian S, Ambler, S Kelly, Haughian, James M, Pinto, Mauricio P, Jedlicka, Paul, Joensuu, Kristiina, Heikkilä, Päivi, Horwitz, Kathryn B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303198/ https://www.ncbi.nlm.nih.gov/pubmed/25475897 http://dx.doi.org/10.1186/s13058-014-0489-4 |
Ejemplares similares
-
Modeling luminal breast cancer heterogeneity: combination therapy to suppress a hormone receptor-negative, cytokeratin 5-positive subpopulation in luminal disease
por: Knox, Aaron J, et al.
Publicado: (2014) -
ER, PR, HER2, Ki-67 and CK5 in Early and Late Relapsing Breast Cancer—Reduced CK5 Expression in Metastases
por: Joensuu, Kristiina, et al.
Publicado: (2013) -
Arousal-based pupil modulation is dictated by luminance
por: Pan, Jasmine, et al.
Publicado: (2022) -
Quantities of CD3+, CD8+ and CD56+ lymphocytes decline in breast cancer recurrences while CD4+ remain similar
por: Mutka, Minna, et al.
Publicado: (2023) -
Clever-1 positive macrophages in breast cancer
por: Mutka, Minna, et al.
Publicado: (2022)